These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 33733693

  • 1. Radiomics on radiography predicts giant cell tumor histologic response to denosumab.
    Chang YC, Stoyanova R, Danilova S, Pretell-Mazzini JA, Kerr DA, Wilky BA, Subhawong T.
    Skeletal Radiol; 2021 Sep; 50(9):1881-1887. PubMed ID: 33733693
    [Abstract] [Full Text] [Related]

  • 2. Response evaluation of giant-cell tumor of bone treated by denosumab: Histogram and texture analysis of CT images.
    Yi J, Lee YH, Kim SK, Kim SH, Song HT, Shin KH, Suh JS.
    J Orthop Sci; 2018 May; 23(3):570-577. PubMed ID: 29429890
    [Abstract] [Full Text] [Related]

  • 3. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone].
    Sørensen AL, Hansen RL, Jørgensen PH.
    Ugeskr Laeger; 2016 Sep 05; 178(36):. PubMed ID: 27593237
    [Abstract] [Full Text] [Related]

  • 4. Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery.
    von Borstel D, A Taguibao R, A Strle N, E Burns J.
    Skeletal Radiol; 2017 Apr 05; 46(4):571-578. PubMed ID: 28188337
    [Abstract] [Full Text] [Related]

  • 5. Radiological findings of denosumab treatment for giant cell tumours of bone.
    van Langevelde K, McCarthy CL.
    Skeletal Radiol; 2020 Sep 05; 49(9):1345-1358. PubMed ID: 32335707
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnosis and monitoring denosumab therapy of giant cell tumors of bone: radiologic-pathologic correlation.
    Lejoly M, Van Den Berghe T, Creytens D, Huysse W, Lapeire L, Sys G, Verstraete K.
    Skeletal Radiol; 2024 Feb 05; 53(2):353-364. PubMed ID: 37515643
    [Abstract] [Full Text] [Related]

  • 10. Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab.
    Mukaihara K, Suehara Y, Kohsaka S, Akaike K, Tanabe Y, Kubota D, Ishii M, Fujimura T, Kazuno S, Okubo T, Takagi T, Yao T, Kaneko K, Saito T.
    PLoS One; 2016 Feb 05; 11(2):e0148401. PubMed ID: 26863138
    [Abstract] [Full Text] [Related]

  • 11. Giant cell tumor of bone under Denosumab treatment.
    Wendling D, Guillot X, Sondag M, Chaigneau L, Aubry S, Prati C.
    Joint Bone Spine; 2018 Jul 05; 85(4):491. PubMed ID: 28970075
    [No Abstract] [Full Text] [Related]

  • 12. Ultra-Short Course of Neo-Adjuvant Denosumab for Nerve-Sparing Surgery for Giant Cell Tumor of Bone in Sacrum.
    Liang H, Liu X, Yang Y, Guo W, Yang R, Tang X, Yan T, Li Y, Tang S, Li D, Qu H, Dong S, Ji T, Du Z, Zang J.
    Spine (Phila Pa 1976); 2022 May 01; 47(9):691-701. PubMed ID: 34961753
    [Abstract] [Full Text] [Related]

  • 13. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
    Palmerini E, Chawla NS, Ferrari S, Sudan M, Picci P, Marchesi E, Leopardi MP, Syed I, Sankhala KK, Parthasarathy P, Mendanha WE, Pierini M, Paioli A, Chawla SP.
    Eur J Cancer; 2017 May 01; 76():118-124. PubMed ID: 28324746
    [Abstract] [Full Text] [Related]

  • 14. Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial.
    Ueda T, Morioka H, Nishida Y, Kakunaga S, Tsuchiya H, Matsumoto Y, Asami Y, Inoue T, Yoneda T.
    Ann Oncol; 2015 Oct 01; 26(10):2149-54. PubMed ID: 26205395
    [Abstract] [Full Text] [Related]

  • 15. Response to Denosumab in 2 Children With Recurrent Giant Cell Tumor of the Bone With Pulmonary Metastasis.
    Reddy K, Ramirez L, Kukreja K, Venkatramani R.
    J Pediatr Hematol Oncol; 2021 Mar 01; 43(2):e215-e218. PubMed ID: 31714440
    [Abstract] [Full Text] [Related]

  • 16. The role of Denosumab in joint preservation for patients with giant cell tumour of bone.
    Perrin DL, Visgauss JD, Wilson DA, Griffin AM, Abdul Razak AR, Ferguson PC, Wunder JS.
    Bone Joint J; 2021 Jan 01; 103-B(1):184-191. PubMed ID: 33380180
    [Abstract] [Full Text] [Related]

  • 17. Effect of denosumab in treatment of unresectable spine and sacrum giant cell tumor of bone.
    Arefpour A, Shafieesabet M, Chehrassan M, Ahmadzadehnanva A, Ghandhari H.
    Musculoskelet Surg; 2024 Mar 01; 108(1):93-98. PubMed ID: 37940782
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
    Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS.
    Eur J Cancer; 2016 May 01; 59():1-12. PubMed ID: 26990281
    [Abstract] [Full Text] [Related]

  • 19. Spectrum of histological features of Denosumab treated Giant Cell Tumor of Bone; potential pitfalls and diagnostic challenges for pathologists.
    Tariq MU, Umer M, Khan Z, Saeed J, Siddiqui MA, Din NU.
    Ann Diagn Pathol; 2020 Apr 01; 45():151479. PubMed ID: 32088577
    [Abstract] [Full Text] [Related]

  • 20. Tumor Growth Rate in Spinal Giant Cell Tumors of Bone and Association With the Immune Microenvironment and Denosumab Treatment Responsiveness: A Multicenter Study.
    Zheng BW, Zheng BY, Niu HQ, Yang YF, Zhu GQ, Li J, Zhang TL, Zou MX.
    Neurosurgery; 2023 Mar 01; 92(3):524-537. PubMed ID: 36409294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.